JP2005237328A5 - - Google Patents

Download PDF

Info

Publication number
JP2005237328A5
JP2005237328A5 JP2004053795A JP2004053795A JP2005237328A5 JP 2005237328 A5 JP2005237328 A5 JP 2005237328A5 JP 2004053795 A JP2004053795 A JP 2004053795A JP 2004053795 A JP2004053795 A JP 2004053795A JP 2005237328 A5 JP2005237328 A5 JP 2005237328A5
Authority
JP
Japan
Prior art keywords
base sequence
immunostimulatory oligonucleotide
immunomodulator
seq
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004053795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005237328A (ja
JP3976742B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004053795A priority Critical patent/JP3976742B2/ja
Priority claimed from JP2004053795A external-priority patent/JP3976742B2/ja
Priority to PCT/JP2005/003693 priority patent/WO2005083076A1/ja
Priority to US10/590,761 priority patent/US7718623B2/en
Publication of JP2005237328A publication Critical patent/JP2005237328A/ja
Publication of JP2005237328A5 publication Critical patent/JP2005237328A5/ja
Application granted granted Critical
Publication of JP3976742B2 publication Critical patent/JP3976742B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004053795A 2004-02-27 2004-02-27 インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド Expired - Lifetime JP3976742B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2004053795A JP3976742B2 (ja) 2004-02-27 2004-02-27 インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド
PCT/JP2005/003693 WO2005083076A1 (ja) 2004-02-27 2005-02-25 インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド
US10/590,761 US7718623B2 (en) 2004-02-27 2005-02-25 Immunostimulatory oligonucleotide that induces interferon alpha

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004053795A JP3976742B2 (ja) 2004-02-27 2004-02-27 インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド

Publications (3)

Publication Number Publication Date
JP2005237328A JP2005237328A (ja) 2005-09-08
JP2005237328A5 true JP2005237328A5 (OSRAM) 2006-10-12
JP3976742B2 JP3976742B2 (ja) 2007-09-19

Family

ID=34908763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004053795A Expired - Lifetime JP3976742B2 (ja) 2004-02-27 2004-02-27 インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド

Country Status (3)

Country Link
US (1) US7718623B2 (OSRAM)
JP (1) JP3976742B2 (OSRAM)
WO (1) WO2005083076A1 (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4817599B2 (ja) * 2003-12-25 2011-11-16 独立行政法人科学技術振興機構 免疫活性増強剤とこれを用いた免疫活性の増強方法
CN101460620B (zh) * 2006-05-31 2012-02-15 东丽株式会社 免疫刺激寡核苷酸及其药物用途
JP5280432B2 (ja) * 2007-04-27 2013-09-04 ヒュンジン ヤン 比重の増加した細胞培養用支持体及びその製造方法
WO2009069448A1 (ja) * 2007-11-28 2009-06-04 Toray Industries, Inc. 日本脳炎ワクチン用のアジュバント及び日本脳炎ワクチン
WO2009069447A1 (ja) * 2007-11-28 2009-06-04 Toray Industries, Inc. インフルエンザワクチン用のアジュバント及びインフルエンザワクチン
JP5359883B2 (ja) * 2007-11-28 2013-12-04 東レ株式会社 肝炎の治療剤又は予防剤
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
IN2012DN00720A (OSRAM) 2009-07-06 2015-06-19 Ontorii Inc
WO2012039448A1 (ja) 2010-09-24 2012-03-29 株式会社キラルジェン 不斉補助基
GB201021867D0 (en) * 2010-12-23 2011-02-02 Mologen Ag Non-coding immunomodulatory DNA construct
JP5906019B2 (ja) * 2011-03-31 2016-04-20 国立大学法人福井大学 免疫刺激ｇ９．１の抗結核ブースターワクチン創出への応用
MX347361B (es) 2011-07-19 2017-04-12 Wave Life Sciences Ltd Metodos para la sintesis de acidos nucleicos funcionalizados.
US12268718B2 (en) 2012-01-16 2025-04-08 Labyrinth Holdings Llc Control of cellular redox levels
SG10201605350UA (en) 2012-01-16 2016-08-30 Mckenna Elizabeth Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
AR091569A1 (es) 2012-06-28 2015-02-11 Intervet Int Bv Receptores de tipo toll
EP2872147B1 (en) 2012-07-13 2022-12-21 Wave Life Sciences Ltd. Method for making chiral oligonucleotides
EP2872485B1 (en) 2012-07-13 2020-12-16 Wave Life Sciences Ltd. Asymmetric auxiliary group
AU2013287630B2 (en) * 2012-07-13 2017-05-25 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
WO2014047588A1 (en) * 2012-09-21 2014-03-27 Elizabeth Mckenna Naturally occurring cpg oligonucleotide compositions and therapeutic applications thereof
US10144933B2 (en) 2014-01-15 2018-12-04 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
EP3095460A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
CN106068325B (zh) 2014-01-16 2021-07-09 波涛生命科学有限公司 手性设计
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
WO2023049275A2 (en) * 2021-09-23 2023-03-30 Arnay Sciences, Llc Cyclic structured oligonucleotides as therapeutic agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0468520A3 (en) * 1990-07-27 1992-07-01 Mitsui Toatsu Chemicals, Inc. Immunostimulatory remedies containing palindromic dna sequences
ATE432348T1 (de) 1997-06-06 2009-06-15 Univ California Inhibitoren von immunstimulatorischen dna sequenz aktivität
CA2323929C (en) 1998-04-03 2004-03-09 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
AU783118B2 (en) * 1999-09-27 2005-09-29 Coley Pharmaceutical Gmbh Methods related to immunostimulatory nucleic acid-induced interferon
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
WO2002002172A1 (en) * 2000-06-30 2002-01-10 Univ Jefferson Dna palindrome - oligoguanylic acid compositions and uses thereof
US20030050268A1 (en) * 2001-03-29 2003-03-13 Krieg Arthur M. Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
ES2335979T3 (es) 2001-09-14 2010-04-07 Cytos Biotechnology Ag Empaquetamiento de cpg inmunoestimuladores en particulas similares a virus: metodo de preparacion y su uso.
WO2003024480A2 (en) 2001-09-14 2003-03-27 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
PL375306A1 (en) 2002-06-20 2005-11-28 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use

Similar Documents

Publication Publication Date Title
JP2005237328A5 (OSRAM)
JP2007522094A5 (OSRAM)
JP2006516528A5 (OSRAM)
JP2006141398A5 (OSRAM)
JP2007302683A5 (OSRAM)
JP2006526031A5 (OSRAM)
EP1728863A3 (en) C-class oligonucleotide analogs with enhanced immunostimulatory potency
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
NO20031646D0 (no) Ajuvantsammensetning omfattende et immunostimulatorisk oligonukleotid og entokol
JP2001131087A5 (OSRAM)
JP2005532372A5 (OSRAM)
MXPA03011972A (es) Arilaminas para tratamiento de condiciones asociadas con gsk-3.
JP2007515393A5 (OSRAM)
JP2002506648A5 (OSRAM)
JP2004533246A5 (OSRAM)
JP2005538045A5 (OSRAM)
SE0102440D0 (sv) New compound
DE502004005560D1 (de) Pharmazeutische formulierungen enthaltend hochreine basen von 3,3-diphenylpropylaminmonoestern
JP2005509503A5 (OSRAM)
JP2004532624A5 (OSRAM)
JP2008503221A5 (OSRAM)
JP2006512078A5 (OSRAM)
JP2006507295A5 (OSRAM)
JP2020117504A5 (OSRAM)
JP2009505991A5 (OSRAM)